As of 2025-07-12, the EV/EBITDA ratio of Revolution Medicines Inc (RVMD) is -10.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RVMD's latest enterprise value is 6,748.43 mil USD. RVMD's TTM EBITDA according to its financial statements is -639.94 mil USD. Dividing these 2 quantities gives us the above RVMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-07-10 | -10.69 |
| 2025-07-09 | -10.69 |
| 2025-07-08 | -10.09 |
| 2025-07-07 | -10.15 |
| 2025-07-03 | -10.50 |
| 2025-07-02 | -10.30 |
| 2025-07-01 | -10.22 |
| 2025-06-30 | -10.19 |
| 2025-06-27 | -10.22 |
| 2025-06-26 | -10.39 |
| 2025-06-25 | -10.66 |
| 2025-06-24 | -11.13 |
| 2025-06-23 | -11.13 |
| 2025-06-20 | -11.02 |
| 2025-06-18 | -11.10 |
| 2025-06-17 | -10.87 |
| 2025-06-16 | -11.05 |
| 2025-06-13 | -11.29 |
| 2025-06-12 | -11.44 |
| 2025-06-11 | -11.35 |
| 2025-06-10 | -11.70 |
| 2025-06-09 | -11.29 |
| 2025-06-06 | -11.44 |
| 2025-06-05 | -11.18 |
| 2025-06-04 | -11.23 |
| 2025-06-03 | -11.29 |
| 2025-06-02 | -11.31 |
| 2025-05-30 | -10.95 |
| 2025-05-29 | -10.86 |
| 2025-05-28 | -10.46 |
| 2025-05-27 | -10.24 |
| 2025-05-23 | -11.05 |
| 2025-05-22 | -10.77 |
| 2025-05-21 | -10.75 |
| 2025-05-20 | -11.26 |
| 2025-05-19 | -11.10 |
| 2025-05-16 | -10.99 |
| 2025-05-15 | -10.96 |
| 2025-05-14 | -10.97 |
| 2025-05-13 | -11.11 |
| 2025-05-12 | -11.67 |
| 2025-05-09 | -11.24 |
| 2025-05-08 | -11.68 |
| 2025-05-07 | -10.44 |
| 2025-05-06 | -10.38 |
| 2025-05-05 | -11.06 |
| 2025-05-02 | -11.33 |
| 2025-05-01 | -11.31 |
| 2025-04-30 | -11.23 |
| 2025-04-29 | -11.32 |